Sort by
Medicine and Dentistry
Endometrial Cancer
85%
Disease
50%
Cancer
48%
Symptomatic Treatment
42%
Hysterectomy
38%
Krukenberg Tumor
38%
Consultation
33%
Abdominal Hysterectomy
33%
Gynecological Oncology
32%
Cancer Survival
28%
Trophoblastic Disease
28%
Gestational Trophoblastic Disease
28%
Carboplatin
28%
Paclitaxel
28%
Malignant Neoplasm
25%
Urban Population
23%
Venous Thromboembolism
22%
Ovarian Cancer
22%
Uterine Cancer
21%
Body Mass Index
21%
Arm
21%
Quality of Life
21%
Symptom
19%
Recurrent Disease
19%
Overall Survival
18%
Adenocarcinoma
17%
Adverse Event
17%
Patient Referral
17%
Oncologist
17%
Uterine Serous Carcinoma
17%
Female Genital Tract Cancer
16%
Medical Record
16%
Carcinosarcoma
16%
Proportional Hazards Model
16%
End of Life Care
15%
Emergency Department
14%
Mannose Binding Lectin
14%
Endometrium Carcinoma
14%
Medicare
14%
Opiate
14%
Extracorporeal Membrane Oxygenation
14%
Physical Activity
14%
Atrophic Vaginitis
14%
Anamnesis
14%
Glycon
14%
Intraperitoneal Chemotherapy
14%
Patient-Reported Outcome
14%
Direct Oral Anticoagulant
14%
Adrenal Gland
14%
Laparotomy
14%
Keyphrases
Uterine Serous Carcinoma
42%
Endometrial Cancer
34%
Cancer-specific Survival
28%
Dostarlimab
28%
ENGOT
28%
Carboplatin-paclitaxel
25%
Hazard Ratio
20%
Chemotherapy
17%
Gynecologic Cancer Survivors
15%
Multispecialty Practice
14%
Sexual History Taking
14%
Saddle Pulmonary Emboli
14%
Robot-assisted Laparoscopy
14%
CO2e
14%
Carbon Footprint
14%
Metformin Use
14%
Atrophic Vaginitis
14%
Women's Decision Making
14%
Ovarian Metastasis
14%
Human Epidermal Growth Factor Receptor 2/neu
14%
Ancillary Support
14%
Gestational Trophoblastic Neoplasia
14%
Fellowship Interviews
14%
Robotic Hysterectomy
14%
Laparoscopic Hysterectomy
14%
Morbidly Obese Patients
14%
Trastuzumab
14%
Healthcare Management
14%
Direct Hospital Costs
14%
Robot-assisted
14%
Total Abdominal Hysterectomy
14%
Delayed Discharge
14%
Symptom Management
14%
Risk Factors
14%
Statin Use
14%
Gynecologic Malignancies
14%
Palliative Care
14%
Fitbit
14%
Physical Activity Monitor
14%
Postpartum Patient
14%
Diethylstilbestrol
14%
Advanced Ovarian Cancer
14%
Insertional Oncogenesis
14%
Randomized Phase II Trial
14%
Sexual Dysfunction
14%
Runt-related Transcription Factor 3 (RUNX3)
14%
Overexpressing
14%
Venous Thromboembolism
14%
Serous Cystadenofibroma
14%
Recurrent Endometrial Cancer
14%
Nursing and Health Professions
Endometrium Cancer
100%
Palliative Therapy
42%
Quality of Life
38%
Body Mass
34%
Waist Circumference
28%
Malignant Neoplasm
20%
Self-Efficacy
19%
Ovary Cancer
17%
End of Life Care
16%
Cancer Survival
14%
Symptom Management
14%
Six Minute Walk Test
14%
Laparoscopy
14%
Diethylstilbestrol
14%
Hospital Cost
14%
Pilot Study
14%
Hospital Readmission
14%
Ovary Carcinoma
14%
Laparotomy
14%
Body Composition
11%
Step Count
10%
Patient Social Context
9%
Counseling
9%
Cancer Therapy
9%
Functional Assessment
9%
Disease
8%
Montreal Cognitive Assessment
8%
Medical Record
7%
Analysis of Variance
7%
Effect Size
7%
Student T Test
5%
Disease Specific Survival
5%
Proportional Hazards Model
5%
Body Weight
5%
